JP2001206832A - Cosmetic - Google Patents

Cosmetic

Info

Publication number
JP2001206832A
JP2001206832A JP2000016217A JP2000016217A JP2001206832A JP 2001206832 A JP2001206832 A JP 2001206832A JP 2000016217 A JP2000016217 A JP 2000016217A JP 2000016217 A JP2000016217 A JP 2000016217A JP 2001206832 A JP2001206832 A JP 2001206832A
Authority
JP
Japan
Prior art keywords
skin
cosmetic
effect
component
transparency
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000016217A
Other languages
Japanese (ja)
Inventor
Chiaki Sone
千晶 曽根
Hideo Kimura
秀雄 木村
Junsuke Koba
淳介 木場
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP2000016217A priority Critical patent/JP2001206832A/en
Publication of JP2001206832A publication Critical patent/JP2001206832A/en
Pending legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To obtain a cosmetic capable of providing the skin with not only whiteness but also lightness/transparent feeling of the essential skin and an excellent skin care effect when the cosmetic is used. SOLUTION: This cosmetic comprises (A) a water-soluble moisturizing component selected from an amino acid, an organic acid or its salt, a saccharide, urea, glycinebetaine and a guanidine derivative, (B) a blood circulation promotion component and (C) a bleaching component.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、スキンケア効果に
優れ、かつ肌本来の明るさ、透明感を取り戻す効果を有
する化粧料に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a cosmetic having an excellent skin care effect and an effect of restoring the original brightness and transparency of the skin.

【0002】[0002]

【従来の技術】従来、日焼けによる皮膚の黒色化は、皮
膚内に存在するチロシンがチロシナーゼの作用によりメ
ラニン色素となり、このメラニンが過剰に生成すること
に起因するとされている。この色素沈着を予防又は治療
すべく、L−アスコルビン酸及びそれらの誘導体、コロ
イド状硫黄、過酸化水素、ハイドロキノン等の美白成分
を配合してなる化粧料が提案されている。
2. Description of the Related Art Hitherto, blackening of skin due to sunburn has been attributed to the fact that tyrosine present in skin becomes melanin pigment by the action of tyrosinase, and this melanin is excessively produced. In order to prevent or treat this pigmentation, cosmetics comprising a whitening component such as L-ascorbic acid and derivatives thereof, colloidal sulfur, hydrogen peroxide and hydroquinone have been proposed.

【0003】[0003]

【発明が解決しようとする課題】しかしながら、これら
の美白化粧料は保存安定性が不充分であるか、或いは美
白効果が充分に認められないものであったり、又は、色
黒の皮膚を淡色化する効果は認められるものの、スキン
ケア効果に問題が生じるものであって、肌本来の働きを
改善することにより肌本来の明るさ、透明感を期待する
ことは困難であった。従って、単に色素沈着を予防又は
治療するだけでなく、肌本来の明るさと透明感を取り戻
す効果に優れ、かつスキンケア効果の高い化粧料の開発
が望まれている。
However, these whitening cosmetics have insufficient storage stability, or do not have a sufficient whitening effect, or lighten dark skin. Although the effect is recognized, the skin care effect is problematic, and it has been difficult to expect the original brightness and transparency of the skin by improving the original function of the skin. Therefore, there is a demand for the development of a cosmetic that is not only effective in preventing or treating pigmentation, but also has an excellent effect of restoring the original brightness and transparency of the skin and has a high skin care effect.

【0004】[0004]

【課題を解決するための手段】本発明者は美白成分に、
特定の水溶性保湿成分及び血行促進成分を組み合せて配
合すれば、美白効果だけでなく、肌本来の明るさと透明
感の改善効果に優れ、かつスキンケア効果の高い化粧料
が得られることを見出した。
Means for Solving the Problems The present inventor has proposed a whitening ingredient,
It has been found that if a specific water-soluble moisturizing component and a blood circulation promoting component are combined and compounded, not only a whitening effect but also an effect of improving the original brightness and transparency of the skin and a cosmetic having a high skin care effect can be obtained. .

【0005】すなわち、本発明は、次の成分(A)、
(B)及び(C): (A)アミノ酸、有機酸又はその塩、糖類、尿素、グリ
シンベタイン及びグアニジン誘導体から選ばれる水溶性
保湿成分、(B)血行促進成分、(C)美白成分を含有
する化粧料を提供するものである。
That is, the present invention provides the following component (A):
(B) and (C): (A) Contains a water-soluble moisturizing component selected from amino acids, organic acids or salts thereof, saccharides, urea, glycine betaine and guanidine derivatives, (B) a blood circulation promoting component, and (C) a whitening component. To provide cosmetics.

【0006】[0006]

【発明の実施の形態】本発明に用いられる成分(A)
は、水溶性の保湿成分であり、アミノ酸としては、例え
ばグリシン、アラニン、バリン、ロイシン、アルギニ
ン、リジン、グルタミン酸等が挙げられる。有機酸又は
その塩としては、例えばピロリドンカルボン酸ナトリウ
ム、乳酸、コハク酸、乳酸ナトリウム、クエン酸、クエ
ン酸ナトリウム等が挙げられる。糖類としては、ヒアル
ロン酸、コンドロイチン、硫酸デルマタン硫酸、グルコ
ース、マンノース、ガラクトース、マルトース等が挙げ
られる。グリシンベタインとしては、C4〜C24アルキ
ル基を有するグリシンベタインが挙げられる。また、グ
アニジン誘導体としては、特開平10−287541号
記載の次の一般式(1)又は(2)
BEST MODE FOR CARRYING OUT THE INVENTION Component (A) used in the present invention
Is a water-soluble moisturizing component, and examples of amino acids include glycine, alanine, valine, leucine, arginine, lysine, glutamic acid and the like. Examples of the organic acid or a salt thereof include sodium pyrrolidonecarboxylate, lactic acid, succinic acid, sodium lactate, citric acid, sodium citrate and the like. Examples of the saccharide include hyaluronic acid, chondroitin, dermatan sulfate, glucose, mannose, galactose, and maltose. Glycine betaine includes glycine betaine having a C 4 -C 24 alkyl group. As the guanidine derivative, the following general formula (1) or (2) described in JP-A-10-287541.

【0007】[0007]

【化1】 Embedded image

【0008】〔式(1)中、Xは直鎖若しくは分岐鎖の
炭化水素基、又は置換基を有していてもよい芳香環基、
アラルキル基、シクロアルキル基もしくはオキサシクロ
アルキル基を示し、Yは水素原子又は直鎖若しくは分岐
鎖の炭化水素基を示す。式(2)中、A及びBは同一又
は異なっていてもよい炭素数2〜8のアルキレン基を示
し、Dは結合手、−CO−又は置換基を有していてもよ
い炭素数1〜6のアルキレン基を示し、Eは水素原子、
低級アルキル基、アラルキル基又は置換基を有していて
もよいアリール基を示し、mは1〜6の数を示し、nは
0〜6の数を示し、R1は水素原子、低級アルキル基又
は-(AO)m-(BO)n-D-Eを示す。ただし、R1がメチル基の
場合-(AO)m-(BO)n-D-Eはヒドロキシエチル基ではない〕
で表されるグアニジン誘導体又はその酸付加塩が挙げら
れる。
[In the formula (1), X is a linear or branched hydrocarbon group, or an aromatic ring group which may have a substituent,
It represents an aralkyl group, a cycloalkyl group or an oxacycloalkyl group, and Y represents a hydrogen atom or a linear or branched hydrocarbon group. In the formula (2), A and B represent an alkylene group having 2 to 8 carbon atoms which may be the same or different, and D represents a bond, -CO- or 1 to 1 carbon atoms which may have a substituent. 6 represents an alkylene group, E is a hydrogen atom,
A lower alkyl group, an aralkyl group or an aryl group which may have a substituent, m represents a number of 1 to 6, n represents a number of 0 to 6, R 1 represents a hydrogen atom, a lower alkyl group; Or-(AO) m- (BO) n -DE. However, when R 1 is a methyl group,-(AO) m- (BO) n -DE is not a hydroxyethyl group.
Or an acid addition salt thereof.

【0009】上記式(1)のグアニジン誘導体のうち、
特に、メチルグアニジン、エチルグアニジン、n−プロ
ピルグアニジン、イソプロピルグアニジン、n−ブチル
グアニジン、2−メチルプロピルグアニジン、t−ブチ
ルグアニジン、n−ペンチルグアニジン、n−ヘキシル
グアニジン、フェニルグアニジン、N−メチル−N−フ
ェニルグアニジン、4−ヒドロキシフェニルグアニジ
ン、4−メトキシフェニルグアニジン、4−エトキシフ
ェニルグアニジン、3−(4−グアニジノフェニル)プ
ロパン酸、4−(4−グアニジノフェニル)ブタン酸、
2−メトキシ−5−メチルフェニルグアニジン、シクロ
ヘキシルグアニジン、ベンジルグアニジン、グルコピラ
ノシルグアニジン、酢酸4−グアニジノフェニルが好ま
しい。
Among the guanidine derivatives of the above formula (1),
In particular, methylguanidine, ethylguanidine, n-propylguanidine, isopropylguanidine, n-butylguanidine, 2-methylpropylguanidine, t-butylguanidine, n-pentylguanidine, n-hexylguanidine, phenylguanidine, N-methyl-N -Phenylguanidine, 4-hydroxyphenylguanidine, 4-methoxyphenylguanidine, 4-ethoxyphenylguanidine, 3- (4-guanidinophenyl) propanoic acid, 4- (4-guanidinophenyl) butanoic acid,
2-methoxy-5-methylphenylguanidine, cyclohexylguanidine, benzylguanidine, glucopyranosylguanidine, 4-guanidinophenyl acetate are preferred.

【0010】また式(2)のグアニジン誘導体のうち、
特に、2−(2−ヒドロキシエトキシ)エチルグアニジ
ン、5−ヒドロキシペンチルグアニジンが好ましい。
Also, among the guanidine derivatives of the formula (2),
Particularly, 2- (2-hydroxyethoxy) ethylguanidine and 5-hydroxypentylguanidine are preferable.

【0011】更に、グアニジン誘導体としては、コハク
酸2−(2−ヒドロキシエトキシ)エチルグアニジンが
特に好ましい。
Furthermore, as the guanidine derivative, 2- (2-hydroxyethoxy) ethyl guanidine succinate is particularly preferred.

【0012】これらの成分(A)は、1種又は2種以上
を組み合せて用いることができ、全組成中に0.005
〜20重量%(以下、単に%で示す)配合するのがスキ
ンケア効果及び肌本来の明るさ、透明感の改善効果の点
で好ましく、特に0.01〜10%、更には0.01〜
5%配合すると更に安定性の点で好ましい。
These components (A) can be used singly or in combination of two or more.
It is preferable to mix it in an amount of from 20 to 20% by weight (hereinafter simply referred to as%) from the viewpoint of skin care effect and effect of improving skin's original brightness and transparency, particularly from 0.01 to 10%, more preferably from 0.01 to 10%.
The addition of 5% is more preferable in terms of stability.

【0013】また、本発明で用いる成分(B)としては
通常化粧料に用いられる血行促進成分であれば特に制限
されず、例えば、ニコチン酸トコフェロール、酢酸トコ
フェロール、ニコチン酸アミド、米胚芽油、ボダイジュ
エキス、マロニエエキス、ユズ抽出物等が挙げられ、ユ
ズ抽出物、ボダイジュエキス、ニコチン酸アミドが特に
好ましい。
The component (B) used in the present invention is not particularly limited as long as it is a blood circulation-promoting component usually used in cosmetics, and examples thereof include tocopherol nicotinate, tocopherol acetate, nicotinamide, rice germ oil, bodaiju Extracts, maroni extract, yuzu extract and the like are mentioned, and yuzu extract, bodaiju extract and nicotinamide are particularly preferable.

【0014】かかる成分(B)は1種又は2種以上を組
み合せて用いることができ、ニコチン酸トコフェロー
ル、酢酸トコフェロール、ニコチン酸アミド、米胚芽油
の場合は、全組成中に0.01〜5%配合するのが肌本
来の明るさ、透明感の改善効果の点で好ましく、特に
0.01〜3%、更には0.01〜2%配合すると更に
安定性の点で好ましい。また植物抽出物の場合は乾燥固
形分として、全組成中に0.00001〜5%、特に
0.0001〜3%、更に0.0001〜2%配合する
のが、肌本来の明るさ、透明感の改善効果の点で好まし
い。植物抽出液は抽出液等として市販されているものを
そのまま用いることができる。
The component (B) can be used alone or in combination of two or more. In the case of tocopherol nicotinate, tocopherol acetate, nicotinamide, and rice germ oil, 0.01 to 5 parts % Is preferable from the viewpoint of the effect of improving the original brightness and transparency of the skin, and particularly 0.01 to 2%, more preferably 0.01 to 2%, from the viewpoint of stability. In the case of a plant extract, 0.00001 to 5%, especially 0.0001 to 3%, and more preferably 0.0001 to 2% of dry solid content in the total composition is blended for the original brightness and transparency of the skin. It is preferable in terms of the effect of improving the feeling. As the plant extract, those commercially available as an extract or the like can be used as they are.

【0015】本発明で用いる成分(C)の美白成分とし
ては、通常化粧料に用いられる美白成分であれば特に限
定されず、例えばL−アスコルビン酸及びその誘導体、
アルブチン等のハイドロキノン誘導体、コウジ酸及びそ
の誘導体、エラグ酸及びその誘導体、胎盤抽出物;カミ
ツレ、茶、丁子、営実、地楡、甘草、枇杷、橙皮、高麗
人参、芍薬、山査子、麦門冬、生姜、松笠、桑白皮、厚
朴、インチンコウ、阿仙薬、黄ゴン、アロエ、アルテ
ア、シモツケ、オランダガラシ、キナ、コンフリー、ロ
ーズマリー、ロート等の植物抽出液などが挙げられる。
このうち、カミツレ、アルテア、茶が特に好ましい。
The whitening component of the component (C) used in the present invention is not particularly limited as long as it is a whitening component usually used in cosmetics. For example, L-ascorbic acid and its derivatives,
Hydroquinone derivatives such as arbutin, kojic acid and its derivatives, ellagic acid and its derivatives, placental extracts; chamomile, tea, clove, fruit, groundnut, licorice, loquat, orange peel, ginseng, peony, mountain herb, germ winter And plant extracts such as ginger, matsukasa, mulberry bark, magnolia, chinko, asenyaku, yellow gon, aloe, altea, spirea, dutch mustard, kina, comfrey, rosemary, and funnel.
Of these, chamomile, Altea and tea are particularly preferred.

【0016】成分(C)は1種又は2種以上を組み合せ
て用いることができ、L−アスコルビン酸及びその誘導
体、アルブチン等のハイドロキノン誘導体、コウジ酸及
びその誘導体、エラグ酸及びその誘導体、胎盤抽出物を
用いる場合は、全組成中に0.01〜50%、特に0.
05〜30%、更に0.1〜20%配合するのが充分な
美白効果と肌本来の明るさ、透明感の改善効果の点で好
ましい。また植物抽出物の場合は乾燥固形分として、全
組成中に0.00001〜5%、特に0.0001〜3
%、更に0.0001〜2%配合するのが、充分な美白
効果と肌本来の明るさ、透明感の改善効果の点で好まし
い。植物抽出液は抽出液等として市販されているものを
そのまま用いることもできる。
Component (C) can be used alone or in combination of two or more. L-ascorbic acid and its derivatives, hydroquinone derivatives such as arbutin, kojic acid and its derivatives, ellagic acid and its derivatives, placenta extraction When a substance is used, 0.01 to 50%, especially 0.1%, of the total composition.
It is preferable to add 0.5 to 30%, more preferably 0.1 to 20%, from the viewpoint of a sufficient whitening effect and an effect of improving skin original brightness and transparency. In the case of a plant extract, 0.00001 to 5%, particularly 0.0001 to 3%, as a dry solid content in the whole composition.
%, More preferably 0.0001 to 2%, from the viewpoint of a sufficient whitening effect and an effect of improving the skin's original brightness and transparency. As the plant extract, a commercially available extract or the like can be used as it is.

【0017】本発明の化粧料は、上記成分(A)、
(B)及び(C)を含有することにより、肌本来の明る
さ及び透明感を改善するとともにスキンケア効果(肌荒
れ改善効果)を有するが、当該効果はそのpHを3〜6
にすると更に顕著に発揮される。すなわち、pH調整剤
を配合してpHを3〜6にすると上記の効果、特にスキ
ンケア効果が向上し、また安全性の点でも好ましい。更
に好ましいpHは、3.5〜5.5である。
The cosmetic of the present invention comprises the above component (A),
By containing (B) and (C), the original brightness and transparency of the skin are improved and a skin care effect (skin roughness improving effect) is obtained.
When it is set, it is more remarkably exhibited. That is, when the pH is adjusted to 3 to 6 by adding a pH adjuster, the above effects, particularly the skin care effect, are improved, and it is also preferable from the viewpoint of safety. A more preferred pH is between 3.5 and 5.5.

【0018】また、本発明の化粧料は、その外観を透明
又は半透明にすると外観上の利点だけでなく、有効成分
が可溶化していることに基づき、前記効果が更に向上す
る。ここで、透明又は半透明とは、島津製作所製の分光
光度計(UV−160)を用いて550nmの透過率を
測定し、コントロールとして蒸留水の透明度を100と
したときに20から100の範囲のものをいう。本発明
化粧料を透明又は半透明にするには、前記成分に水及び
可溶化剤を配合するのが好ましい。ここで可溶化剤とし
ては、親水性界面活性剤、例えば非イオン性界面活性剤
が挙げられる。
Further, the cosmetic of the present invention, when its appearance is made transparent or translucent, has not only an advantage in appearance, but also the above-mentioned effect is further improved based on the fact that the active ingredient is solubilized. Here, the term “transparent or translucent” refers to a range of 20 to 100 when the transmittance of 550 nm is measured using a spectrophotometer (UV-160) manufactured by Shimadzu Corporation and the transparency of distilled water is set to 100 as a control. Means In order to make the cosmetic of the present invention transparent or translucent, it is preferable to mix water and a solubilizer with the above components. Here, the solubilizing agent includes a hydrophilic surfactant, for example, a nonionic surfactant.

【0019】非イオン性界面活性剤としては、例えばポ
リオキシエチレンヒマシ油、ポリオキシエチレンヒマシ
油等のポリオキシエチレンヒマシ油又は硬化ヒマシ油誘
導体;ポリオキシエチレンソルビタンモノステアレー
ト、ポリオキシエチレンソルビタンテトラオレエート等
のポリオキシエチレンソルビタン脂肪酸エステル;ポリ
オキシエチレングリセリルモノイソステアレート、ポリ
オキシエチレングリセリルトリイソステアレート等のポ
リオキシエチレングリコールの脂肪酸エステル;ポリオ
キシエチレンオクチルドデシルエーテル、ポリオキシエ
チレンラウリルエーテルポリオキシエチレンセチルエー
テル、ポリオキシエチレンステアリルエーテル、ポリオ
キシエチレンノニルフェニルエーテル等のポリオキシエ
チレンアルキルエーテルなどのポリオキシエチレン付加
型界面活性剤の他、ポリグリセリンアルキルエーテル、
ポリグリセリン脂肪酸エステル、ショ糖脂肪酸エステル
等が挙げられる。
Examples of the nonionic surfactant include polyoxyethylene castor oil and hydrogenated castor oil derivatives such as polyoxyethylene castor oil and polyoxyethylene castor oil; polyoxyethylene sorbitan monostearate, polyoxyethylene sorbitan tetra Polyoxyethylene sorbitan fatty acid esters such as oleate; fatty acid esters of polyoxyethylene glycol such as polyoxyethylene glyceryl monoisostearate and polyoxyethylene glyceryl triisostearate; polyoxyethylene octyl dodecyl ether, polyoxyethylene lauryl ether Polyoxyethylene alkyl ethers such as polyoxyethylene cetyl ether, polyoxyethylene stearyl ether, and polyoxyethylene nonylphenyl ether; Other polyoxyethylene-added surfactants such as Le, polyglycerol alkyl ethers,
Polyglycerin fatty acid esters, sucrose fatty acid esters and the like can be mentioned.

【0020】親水性界面活性剤の配合量は、安全性の面
から、全組成中に0.05〜30%、特に0.05〜1
0%が好ましい。水は本発明化粧料中に40〜99.9
7%、特に70〜99.97%配合するのが好ましく、
可溶化剤は、成分(A)に対し重量比で0.01:1〜
10:1、特に0.01:1〜5:1が好ましい。
From the viewpoint of safety, the content of the hydrophilic surfactant is 0.05 to 30%, preferably 0.05 to 1% in the total composition.
0% is preferred. Water is 40 to 99.9 in the cosmetic of the present invention.
7%, particularly preferably 70 to 99.97%,
The solubilizing agent is used in a weight ratio of 0.01: 1 to component (A).
10: 1, particularly preferably 0.01: 1 to 5: 1.

【0021】本発明の化粧料には、更に通常化粧品に配
合される他の成分を適宜配合することができる。例えば
さっぱり感を付与する目的で不揮発性シリコーンを、肌
へののびとなじみ感をよくする目的でスクワラン、脂肪
酸エステル等の液体油を配合することができる他、紫外
線吸収剤、キレート剤、防腐剤、色素、香料、粘度調整
剤、抗炎症剤等の薬効剤等を配合することができる。
The cosmetic of the present invention may further contain other components which are usually added to cosmetics. For example, non-volatile silicone can be blended with liquid oil such as squalane and fatty acid ester for the purpose of imparting a refreshing feeling, and squalane and fatty acid ester can be blended with the purpose of improving spreadability and familiarity with the skin, as well as ultraviolet absorbers, chelating agents, and preservatives. And a medicinal agent such as a pigment, a fragrance, a viscosity modifier, and an anti-inflammatory agent.

【0022】本発明化粧料は、前記成分を配合して常法
により製造され、その形態としては化粧水、ローショ
ン、美容液、乳液、クリーム等が挙げられるが、このう
ち化粧水、ローション、美容液が好ましい。
The cosmetic of the present invention is produced by a conventional method by blending the above-mentioned components. Examples of the form include lotion, lotion, serum, milky lotion, cream and the like. Among them, lotion, lotion and beauty Liquids are preferred.

【0023】本発明化粧料は、通常の基礎化粧品と同様
に手やコットン等で皮膚に塗布することにより使用する
のが好ましい。
The cosmetic of the present invention is preferably used by applying it to the skin with hands or cotton or the like in the same manner as ordinary basic cosmetics.

【0024】[0024]

【実施例】実施例1〜17及び比較例1〜3 表1〜10に示す処方の透明又は半透明ローションを調
製し、荒れ肌改善効果(スキンケア効果);及び肌の明
るさ・透明感付与効果を評価した。結果を表1〜10に
示す。
Examples 1 to 17 and Comparative Examples 1 to 3 Transparent or translucent lotions having the formulations shown in Tables 1 to 10 were prepared, and the effect of improving rough skin (skin care effect); and the effect of imparting skin brightness and transparency. Was evaluated. The results are shown in Tables 1 to 10.

【0025】[0025]

【表1】 [Table 1]

【0026】[0026]

【表2】 [Table 2]

【0027】[0027]

【表3】 [Table 3]

【0028】[0028]

【表4】 [Table 4]

【0029】[0029]

【表5】 [Table 5]

【0030】[0030]

【表6】 [Table 6]

【0031】[0031]

【表7】 [Table 7]

【0032】[0032]

【表8】 [Table 8]

【0033】[0033]

【表9】 [Table 9]

【0034】[0034]

【表10】 [Table 10]

【0035】〔評価方法〕 1)荒れ肌改善効果の評価 人前腕内側にアセトン/エーテル(容量比1:1)を入
れたガラス製カップ(内径2cm)を装着し、15分間脱
脂処理を行って、荒れ肌を誘発させた。この荒れ肌部の
半分の面積に各試料を一定量毎朝・晩5日間塗布した
後、専門パネラー5人による目視判定により、荒れ肌の
改善効果を観察した。 評価基準 5:非常に回復:パネラー5人全員が顕著に回復したと
判断。 4:回復:パネラー3人以上がおおむね回復したと判
断。 3:やや回復:パネラーの1又は2人がおおむね回復し
たと判断。 2:回復せず:パネラー全員が回復したと判断せず。 1:悪化:パネラーの1人以上が悪化していると判断。
[Evaluation Method] 1) Evaluation of the Effect of Improving Rough Skin A glass cup (inner diameter: 2 cm) containing acetone / ether (volume ratio: 1: 1) was attached to the inner side of a human forearm, and degreased for 15 minutes. Induced rough skin. After applying a fixed amount of each sample to half the area of the rough skin every morning and evening for 5 days, the effect of improving the rough skin was observed by visual judgment by five specialized panelists. Evaluation criterion 5: Extreme recovery: All five panelists judged that the recovery was remarkable. 4: Recovery: Three or more panelists judged that the recovery was almost complete. 3: Slight recovery: One or two of the panelists were judged to have largely recovered. 2: No recovery: All panelists did not judge that recovery was successful. 1: Deteriorated: One or more of the panelists judged that it was deteriorating.

【0036】2)肌の明るさ・透明感の評価 人顔面に、各試料を一定量毎朝・晩30日間塗布した
後、専門パネラー5人による目視評価により、明るさ・
透明感の改善効果を観察した。 5:非常に回復:パネラー5人全員が顕著に回復したと
判断。 4:回復:パネラー3人以上がおおむね回復したと判
断。 3:やや回復:パネラーの1又は2人がおおむね回復し
たと判断。 2:回復せず:パネラー全員が回復したと判断せず。 1:悪化:パネラーの1人以上が悪化していると判断。
2) Evaluation of Skin Brightness and Transparency After applying a fixed amount of each sample to the human face for 30 days every morning and evening, the brightness and transparency were evaluated by visual evaluation by five expert panelists.
The effect of improving the transparency was observed. 5: Extreme recovery: All five panelists judged that the recovery was remarkable. 4: Recovery: Three or more panelists judged that the recovery was almost complete. 3: Slight recovery: One or two of the panelists were judged to have largely recovered. 2: No recovery: All panelists did not judge that recovery was successful. 1: Deteriorated: One or more of the panelists judged that it was deteriorating.

【0037】表1〜10より、成分(A)、(B)及び
(C)を配合した化粧料は、肌の明るさ及び透明感改善
効果に優れるとともに荒れ肌改善効果にも優れているこ
とがわかる。なお、表1〜10中の肌の明るさ・透明感
改善効果の評価基準である5と4の間の差は目視により
明らかに差のあるものであった。
From Tables 1 to 10, it can be seen that the cosmetics containing the components (A), (B) and (C) are excellent in the effect of improving skin brightness and transparency and also in the effect of improving rough skin. Understand. In addition, the difference between 5 and 4, which are the evaluation criteria of the skin brightness / transparency improvement effect in Tables 1 to 10, was clearly different visually.

【0038】[0038]

【発明の効果】本発明の化粧料を用いれば、肌に白さだ
けでなく肌本来の明るさ・透明感を付与でき、かつ優れ
たスキンケア効果も得られる。
By using the cosmetic of the present invention, not only whiteness but also the original brightness and transparency of the skin can be imparted to the skin, and an excellent skin care effect can be obtained.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 木場 淳介 東京都墨田区文花2−1−3 花王株式会 社研究所内 Fターム(参考) 4C083 AA072 AA112 AA122 AB282 AC102 AC122 AC182 AC231 AC292 AC302 AC482 AC581 AC582 AC612 AC642 AC681 AC711 AC741 AC742 AC842 AD191 AD352 AD662 BB51 CC01 CC04 DD01 DD23 EE12 EE16  ────────────────────────────────────────────────── ─── Continuing on the front page (72) Inventor Junsuke Kiba 2-1-3 Bunka, Sumida-ku, Tokyo F-term in Kao Corporation Research Laboratories 4C083 AA072 AA112 AA122 AB282 AC102 AC122 AC182 AC231 AC292 AC302 AC482 AC581 AC582 AC612 AC642 AC681 AC711 AC741 AC742 AC842 AD191 AD352 AD662 BB51 CC01 CC04 DD01 DD23 EE12 EE16

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 次の成分(A)、(B)及び(C) (A)アミノ酸、有機酸又はその塩、糖類、尿素、グリ
シンベタイン及びグアニジン誘導体から選ばれる水溶性
保湿成分、(B)血行促進成分、(C)美白成分を含有
する化粧料。
1. The following components (A), (B) and (C): (A) a water-soluble humectant selected from amino acids, organic acids or salts thereof, saccharides, urea, glycine betaine and guanidine derivatives, (B) Cosmetics containing a blood circulation promoting component and (C) a whitening component.
【請求項2】 pHが3〜6である請求項1記載の化粧
料。
2. The cosmetic according to claim 1, which has a pH of 3 to 6.
JP2000016217A 2000-01-25 2000-01-25 Cosmetic Pending JP2001206832A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000016217A JP2001206832A (en) 2000-01-25 2000-01-25 Cosmetic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000016217A JP2001206832A (en) 2000-01-25 2000-01-25 Cosmetic

Publications (1)

Publication Number Publication Date
JP2001206832A true JP2001206832A (en) 2001-07-31

Family

ID=18543388

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000016217A Pending JP2001206832A (en) 2000-01-25 2000-01-25 Cosmetic

Country Status (1)

Country Link
JP (1) JP2001206832A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2844716A1 (en) * 2002-09-23 2004-03-26 Marcel Jacques Chicouri Synergistic composition for hygiene and prophylactic treatment of feet of diabetics, comprising anti-dehydration agent, microcirculation modulator and antiseptic
US7792695B2 (en) 2006-08-04 2010-09-07 International Business Machines Corporation Apparatus, program, and method for displaying benefit values of a product

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2844716A1 (en) * 2002-09-23 2004-03-26 Marcel Jacques Chicouri Synergistic composition for hygiene and prophylactic treatment of feet of diabetics, comprising anti-dehydration agent, microcirculation modulator and antiseptic
US7792695B2 (en) 2006-08-04 2010-09-07 International Business Machines Corporation Apparatus, program, and method for displaying benefit values of a product

Similar Documents

Publication Publication Date Title
WO2005087182A1 (en) Functional powders
JP2001213754A (en) Cosmetic
JP2003095915A (en) Skin care composition
JP4667336B2 (en) Skin preparation
JP2000128728A (en) Cosmetic composition
JP6194165B2 (en) Topical skin preparation
JPH11286423A (en) Composition for suppressing body odor
JPH0532533A (en) Cosmetic
JP2000038334A (en) Bleaching cosmetic containing resorcinol derivative
JPH1112117A (en) Cosmetic composition or pharmaceutical composition
JP2002114685A (en) Melanogenesis inhibitor and bleaching agent comprising ergosterol derivative and composition containing ergosterol derivative
JP2000256171A (en) Cosmetic composition
JP2001206832A (en) Cosmetic
JP4032246B2 (en) White hair prevention and improvement agent
JP2008094799A (en) Sulfated glycosaminoglycan production promoter and external preparation for skin containing the same
JP2001131031A (en) Composition for scalp and hair
JP4076477B2 (en) Skin preparation
JPH11292752A (en) Beautifully whitening agent and composition for external use for skin
JP2001206833A (en) Cosmetic
JP3083105B2 (en) Cosmetics
JPH11286425A (en) Composition for suppressing aged person smell
JP2000063255A (en) Preparation for external use for skin
KR102354352B1 (en) Oil-in- water cosmetic composition comprising physical sunscreen
JP2006137705A (en) Melanogenesis inhibitor and skin care preparation for external use
JP2005068043A (en) Skin softening agent

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060816

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20060816

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20071221

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080108

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20080430